Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
17.03
+0.83 (5.12%)
At close: Jun 6, 2025, 4:00 PM
17.03
0.00 (0.00%)
After-hours: Jun 6, 2025, 4:58 PM EDT

Biohaven Statistics

Total Valuation

Biohaven has a market cap or net worth of $1.74 billion. The enterprise value is $1.45 billion.

Market Cap 1.74B
Enterprise Value 1.45B

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

Biohaven has 102.11 million shares outstanding. The number of shares has increased by 29.20% in one year.

Current Share Class 102.11M
Shares Outstanding 102.11M
Shares Change (YoY) +29.20%
Shares Change (QoQ) +0.88%
Owned by Insiders (%) 11.54%
Owned by Institutions (%) 85.12%
Float 84.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 28.70
PB Ratio 6.37
P/TBV Ratio 7.24
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.14.

Current Ratio 2.33
Quick Ratio 1.97
Debt / Equity 0.14
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -316.82% and return on invested capital (ROIC) is -181.93%.

Return on Equity (ROE) -316.82%
Return on Assets (ROA) -129.99%
Return on Invested Capital (ROIC) -181.93%
Return on Capital Employed (ROCE) -309.43%
Revenue Per Employee n/a
Profits Per Employee -$3.47M
Employee Count 256
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Biohaven has paid $775,000 in taxes.

Income Tax 775,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -51.34% in the last 52 weeks. The beta is 3.64, so Biohaven's price volatility has been higher than the market average.

Beta (5Y) 3.64
52-Week Price Change -51.34%
50-Day Moving Average 19.19
200-Day Moving Average 35.85
Relative Strength Index (RSI) 46.37
Average Volume (20 Days) 2,330,948

Short Selling Information

The latest short interest is 8.17 million, so 8.00% of the outstanding shares have been sold short.

Short Interest 8.17M
Short Previous Month 7.69M
Short % of Shares Out 8.00%
Short % of Float 9.65%
Short Ratio (days to cover) 3.38

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -912.53M
Pretax Income -750.36M
Net Income -888.60M
EBITDA -903.88M
EBIT -912.53M
Earnings Per Share (EPS) -$9.23
Full Income Statement

Balance Sheet

The company has $322.75 million in cash and $35.51 million in debt, giving a net cash position of $287.24 million or $2.81 per share.

Cash & Cash Equivalents 322.75M
Total Debt 35.51M
Net Cash 287.24M
Net Cash Per Share $2.81
Equity (Book Value) 259.50M
Book Value Per Share 2.54
Working Capital 218.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$644.94 million and capital expenditures -$4.07 million, giving a free cash flow of -$649.01 million.

Operating Cash Flow -644.94M
Capital Expenditures -4.07M
Free Cash Flow -649.01M
FCF Per Share -$6.36
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Biohaven does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.20%
Shareholder Yield -29.20%
Earnings Yield -51.20%
FCF Yield -37.40%
Dividend Details

Analyst Forecast

The average price target for Biohaven is $59.85, which is 251.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target $59.85
Price Target Difference 251.44%
Analyst Consensus Strong Buy
Analyst Count 14
Revenue Growth Forecast (5Y) 6.05%
EPS Growth Forecast (5Y) -23.29%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1